223 related articles for article (PubMed ID: 16509594)
1. Syntheses and biological activities of 3'-azido disaccharide analogues of daunorubicin against drug-resistant leukemia.
Zhang G; Fang L; Zhu L; Zhong Y; Wang PG; Sun D
J Med Chem; 2006 Mar; 49(5):1792-9. PubMed ID: 16509594
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
[TBL] [Abstract][Full Text] [Related]
3. Syntheses and biological activities of disaccharide daunorubicins.
Zhang G; Fang L; Zhu L; Aimiuwu JE; Shen J; Cheng H; Muller MT; Lee GE; Sun D; Wang PG
J Med Chem; 2005 Aug; 48(16):5269-78. PubMed ID: 16078845
[TBL] [Abstract][Full Text] [Related]
4. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
Tapiero H; Nguyen-Ba G; Lampidis TJ
Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
[TBL] [Abstract][Full Text] [Related]
5. Syntheses and biological activities of daunorubicin analogs with uncommon sugars.
Zhu L; Cao X; Chen W; Zhang G; Sun D; Wang PG
Bioorg Med Chem; 2005 Dec; 13(23):6381-7. PubMed ID: 16055335
[TBL] [Abstract][Full Text] [Related]
6. Syntheses and biological activity of bisdaunorubicins.
Zhang G; Fang L; Zhu L; Sun D; Wang PG
Bioorg Med Chem; 2006 Jan; 14(2):426-34. PubMed ID: 16182536
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and biological activities of rebeccamycin analogues with uncommon sugars.
Zhang G; Shen J; Cheng H; Zhu L; Fang L; Luo S; Muller MT; Lee GE; Wei L; Du Y; Sun D; Wang PG
J Med Chem; 2005 Apr; 48(7):2600-11. PubMed ID: 15801850
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activities of a 3'-azido analogue of Doxorubicin against drug-resistant cancer cells.
Yu S; Zhang G; Zhang W; Luo H; Qiu L; Liu Q; Sun D; Wang PG; Wang F
Int J Mol Sci; 2012; 13(3):3671-3684. PubMed ID: 22489175
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
Tsuruo T; Oh-Hara T; Sudo Y; Naito M
Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of daunorubicin analogues containing truncated aromatic cores and unnatural monosaccharide residues.
Fan E; Shi W; Lowary TL
J Org Chem; 2007 Apr; 72(8):2917-28. PubMed ID: 17373847
[TBL] [Abstract][Full Text] [Related]
11. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
[TBL] [Abstract][Full Text] [Related]
12. Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance.
Battisti RF; Zhong Y; Fang L; Gibbs S; Shen J; Nadas J; Zhang G; Sun D
Mol Pharm; 2007; 4(1):140-53. PubMed ID: 17274671
[TBL] [Abstract][Full Text] [Related]
13. [Restorative effect of quercetin on subcellular distribution of daunorubicin in multidrug resistant leukemia cell lines K562/ADM and HL-60/ADM].
Cai X; Chen FY; Han JY; Gu CH; Zhong H; Ouyang RR
Ai Zheng; 2004 Dec; 23(12):1611-5. PubMed ID: 15601547
[TBL] [Abstract][Full Text] [Related]
14. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.
Wasowska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I
Anticancer Res; 2006; 26(3A):2009-12. PubMed ID: 16827137
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships studies in a series of N,N-bis(alkanol)amine aryl esters as P-glycoprotein (Pgp) dependent multidrug resistance (MDR) inhibitors.
Martelli C; Coronnello M; Dei S; Manetti D; Orlandi F; Scapecchi S; Novella Romanelli M; Salerno M; Mini E; Teodori E
J Med Chem; 2010 Feb; 53(4):1755-62. PubMed ID: 20104851
[TBL] [Abstract][Full Text] [Related]
16. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164
[TBL] [Abstract][Full Text] [Related]
17. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
18. Interaction of anthracycline disaccharide with human serum albumin: investigation by fluorescence spectroscopic technique and modeling studies.
Cui F; Qin L; Zhang G; Liu Q; Yao X; Lei B
J Pharm Biomed Anal; 2008 Nov; 48(3):1029-36. PubMed ID: 18722067
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
20. In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia.
Kaspers GL; Veerman AJ; Pieters R; van Zantwijk I; Klumper E; Hählen K; de Waal FC; van Wering ER
Leukemia; 1994 Jan; 8(1):24-9. PubMed ID: 8289494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
